147 related articles for article (PubMed ID: 24724431)
1. [Future direction of pharmacogenomics: identification of genes associated with risk of adverse drug reactions using genome-wide association study].
Mushiroda T
Rinsho Byori; 2014 Jan; 62(1):83-8. PubMed ID: 24724431
[TBL] [Abstract][Full Text] [Related]
2. [Challenge in genome-wide association study for establishment of personalized medicine: focusing on the pharmacogenomics of warfarin and carbamazepine].
Mushiroda T
Rinsho Byori; 2013 May; 61(5):422-7. PubMed ID: 23947182
[TBL] [Abstract][Full Text] [Related]
3. Genome-wide association study identifies variations in 6p21.3 associated with nevirapine-induced rash.
Chantarangsu S; Mushiroda T; Mahasirimongkol S; Kiertiburanakul S; Sungkanuparph S; Manosuthi W; Tantisiriwat W; Charoenyingwattana A; Sura T; Takahashi A; Kubo M; Kamatani N; Chantratita W; Nakamura Y
Clin Infect Dis; 2011 Aug; 53(4):341-8. PubMed ID: 21810746
[TBL] [Abstract][Full Text] [Related]
4. Pharmacogenetic markers of severe cutaneous adverse drug reactions.
Borroni RG
G Ital Dermatol Venereol; 2014 Apr; 149(2):219-26. PubMed ID: 24819643
[TBL] [Abstract][Full Text] [Related]
5. Human leukocyte antigens and drug hypersensitivity.
Chung WH; Hung SI; Chen YT
Curr Opin Allergy Clin Immunol; 2007 Aug; 7(4):317-23. PubMed ID: 17620823
[TBL] [Abstract][Full Text] [Related]
6. Pharmacogenomics of drug-induced hypersensitivity reactions: challenges, opportunities and clinical implementation.
Sukasem C; Puangpetch A; Medhasi S; Tassaneeyakul W
Asian Pac J Allergy Immunol; 2014 Jun; 32(2):111-23. PubMed ID: 25003724
[TBL] [Abstract][Full Text] [Related]
7. Pharmacogenetics of hypersensitivity drug reactions.
Negrini S; Becquemont L
Therapie; 2017 Apr; 72(2):231-243. PubMed ID: 28162244
[TBL] [Abstract][Full Text] [Related]
8. Genetic markers associated with cutaneous adverse drug reactions to allopurinol: a systematic review.
Jarjour S; Barrette M; Normand V; Rouleau JL; Dubé MP; de Denus S
Pharmacogenomics; 2015; 16(7):755-67. PubMed ID: 25965122
[TBL] [Abstract][Full Text] [Related]
9. An update on HLA alleles associated with adverse drug reactions.
Fricke-Galindo I; LLerena A; López-López M
Drug Metab Pers Ther; 2017 May; 32(2):73-87. PubMed ID: 28315856
[TBL] [Abstract][Full Text] [Related]
10. [Pharmacogenetic research in the association between human leukocyte antigen and adverse drug reactions].
Xiong Y; Zhang W; Chen X
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2014 Jul; 39(7):749-57. PubMed ID: 25080918
[TBL] [Abstract][Full Text] [Related]
11. Pharmacogenetic information derived from analysis of HLA alleles.
Gatanaga H; Honda H; Oka S
Pharmacogenomics; 2008 Feb; 9(2):207-14. PubMed ID: 18370849
[TBL] [Abstract][Full Text] [Related]
12. [Pharmacogenetics].
Merk HF
Hautarzt; 2010 Aug; 61(8):650-3. PubMed ID: 20644905
[TBL] [Abstract][Full Text] [Related]
13. Drug-induced hypersensitivity reactions and pharmacogenomics: past, present and future.
Alfirevic A; Pirmohamed M
Pharmacogenomics; 2010 Apr; 11(4):497-9. PubMed ID: 20350129
[TBL] [Abstract][Full Text] [Related]
14. Using genome-wide association studies to identify genes important in serious adverse drug reactions.
Daly AK
Annu Rev Pharmacol Toxicol; 2012; 52():21-35. PubMed ID: 21819236
[TBL] [Abstract][Full Text] [Related]
15. [Cutaneous drug reactions: pharmacogenetic news].
Buffard V; Roujeau JC
Arch Pediatr; 2004 May; 11(5):489-92. PubMed ID: 15135444
[TBL] [Abstract][Full Text] [Related]
16. Pharmacogenomics of adverse drug reactions: implementing personalized medicine.
Wei CY; Lee MT; Chen YT
Hum Mol Genet; 2012 Oct; 21(R1):R58-65. PubMed ID: 22907657
[TBL] [Abstract][Full Text] [Related]
17. Rash in lapatinib-treated patients is not associated with human leukocyte antigen polymorphisms.
Parham LR; Briley LP; King KS; Byrne J; Rappold E; Goss PE; Spraggs CF
Pharmacogenomics; 2015; 16(11):1227-9. PubMed ID: 26265235
[TBL] [Abstract][Full Text] [Related]
18. [Future directions of pharmacogenomics (PGx)].
Kamatani N
Nihon Shinkei Seishin Yakurigaku Zasshi; 2011 Aug; 31(4):149-54. PubMed ID: 21941848
[TBL] [Abstract][Full Text] [Related]
19. Drug hypersensitivity and human leukocyte antigens of the major histocompatibility complex.
Bharadwaj M; Illing P; Theodossis A; Purcell AW; Rossjohn J; McCluskey J
Annu Rev Pharmacol Toxicol; 2012; 52():401-31. PubMed ID: 22017685
[TBL] [Abstract][Full Text] [Related]
20. Characterization of a potential animal model of an idiosyncratic drug reaction: nevirapine-induced skin rash in the rat.
Shenton JM; Teranishi M; Abu-Asab MS; Yager JA; Uetrecht JP
Chem Res Toxicol; 2003 Sep; 16(9):1078-89. PubMed ID: 12971795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
